Attila Lorincz
Inventor
Stats
- 12 US patents issued
- 16 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 12 US Patents Issued
- 16 US Applications Filed
- 189 Total Citation Count
- Feb 14, 2018 Most Recent Filing
- Jan 18, 1994 Earliest Filing
Work History
| Patent Owner | Applications Filed | Year |
|---|---|---|
| DIGENE CORPORATION | 1
1 1 1 1 | 1994
1997 2000 2001 2008 |
| QUEEN MARY UNIVERSITY OF LONDON | 2
| 2013
|
| QIAGEN GAITHERSBURG, INC. | 1
1 2 1 5 2 1 2 | 2001
2003 2005 2008 2009 2010 2012 2013 |
| QUEEN MARY & WESTFIELD COLLEGE | 1
| 2012
|
Inventor Addresses
| Address | Duration |
|---|---|
| Charterhouse Square, GB | Feb 19, 15 - Dec 19, 17 |
| Gaithersburg, MD | May 08, 01 - May 08, 01 |
| London, GB | Feb 20, 14 - Jun 28, 18 |
| North Potomac, MD | May 01, 01 - Oct 21, 08 |
| North Potomac, MD, US | Oct 13, 09 - Mar 14, 17 |
| Potomac, MD, US | Jun 25, 09 - Nov 09, 10 |
Technology Profile
| Technology | Matters | |
|---|---|---|
| C07H: | SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS | 10 |
| C12N: | MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF | 2 |
| C12P: | FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE | 2 |
Patents / Publication
| Patents / Publication # | Year of Publication / Issued | Title | Citations |
|---|---|---|---|
| 2018/0179,597 | 2018 | CANCER MARKERS | 0 |
| 9845506 | 2017 | Method for determining prognosis of prostate cancer in a subject | 0 |
| 9593366 | 2017 | Individually synthesized primers to be used in whole genome amplification | 10 |
| 9115410 | 2015 | Detection of nucleic acids by target-specific hybrid capture method | 10 |
| 2015/0051,084 | 2015 | METHOD FOR DETERMINING PROGNOSIS OF PROSTATE CANCER IN A SUBJECT | 2 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.